FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4307338033> ?p ?o ?g. }

• W4307338033 endingPage "209" @default.
• W4307338033 startingPage "197" @default.
• W4307338033 abstract "Abstract Introduction Neurotoxicity, including optic nerve injury, is one of the most common adverse effects of tacrolimus, the principal calcineurin inhibitor used after kidney transplantation (KTx). The electrophysiologic measurements of both pattern visual evoked potentials (PVEP) and flash visual evoked potentials (FVEP) are valuable when drug-induced optic neuropathy is suspected. Objectives To determine whether VEP measurement is a sensitive and repeatable method for monitoring tacrolimus neurotoxicity. Material and methods This prospective study focused on 35 patients (20 M, 15F, 69 eyes, mean age 43 ± 11 years) who were at a median of 3.0 (IQR, 2.2–3.7) months after KTx at the time of the initial VEP evaluation and were treated with tacrolimus since KTx. The follow-up VEP examination was done after a median of 24 (22–27) months (both VEP measurements followed the ISCEV standards). The P100 wave latency and amplitude for the 1° and 15’ PVEP simulations, and the P2 wave latency and amplitude for the FVEP were analyzed. Results For the 1° checks, the P100 wave latency and amplitude values were significantly worse in the follow-up examination compared to the early post-transplant time-point. Independent associations between FVEP parameters and the tacrolimus blood trough level were observed in the follow-up examination but not at the early post-transplant period. The P2 wave latency correlated with the tacrolimus trough level only in patients treated with the twice-daily, but not the once-daily, tacrolimus formulation. The brain derived neurotrophic factor (BDNF) level correlated with the P100 (15’) latency ( R = 0.499; p = 0.005) and the P2 latency ( R = 0.409; p = 0.025) only in patients treated with the once-daily, but not the twice-daily, tacrolimus formulation. Conclusion The observations in this study may support the rationale for the use of VEP measurements as non-invasive monitoring of subclinical tacrolimus neurotoxicity." @default.
• W4307338033 created "2022-10-31" @default.
• W4307338033 creator A5001517387 @default.
• W4307338033 creator A5048565684 @default.
• W4307338033 creator A5060936030 @default.
• W4307338033 date "2022-10-26" @default.
• W4307338033 modified "2023-10-14" @default.
• W4307338033 title "Visual evoked potentials as a method for the prospective assessment of tacrolimus neurotoxicity in patients after kidney transplantation" @default.
• W4307338033 cites W1580967698 @default.
• W4307338033 cites W1962251849 @default.
• W4307338033 cites W1968522260 @default.
• W4307338033 cites W1968950889 @default.
• W4307338033 cites W1969971113 @default.
• W4307338033 cites W2014760345 @default.
• W4307338033 cites W2019895484 @default.
• W4307338033 cites W2026399893 @default.
• W4307338033 cites W2027019584 @default.
• W4307338033 cites W2027839423 @default.
• W4307338033 cites W2032263502 @default.
• W4307338033 cites W2045575318 @default.
• W4307338033 cites W2046220404 @default.
• W4307338033 cites W2062166039 @default.
• W4307338033 cites W2065960057 @default.
• W4307338033 cites W2066724271 @default.
• W4307338033 cites W2074734666 @default.
• W4307338033 cites W2075615682 @default.
• W4307338033 cites W2084467852 @default.
• W4307338033 cites W2091327620 @default.
• W4307338033 cites W2148728440 @default.
• W4307338033 cites W2169049077 @default.
• W4307338033 cites W2409411671 @default.
• W4307338033 cites W2479415990 @default.
• W4307338033 cites W2512889876 @default.
• W4307338033 cites W2564761214 @default.
• W4307338033 cites W2582521118 @default.
• W4307338033 cites W2949237641 @default.
• W4307338033 cites W3009348385 @default.
• W4307338033 cites W3035509402 @default.
• W4307338033 cites W3123559892 @default.
• W4307338033 cites W4232595225 @default.
• W4307338033 cites W4301627899 @default.
• W4307338033 cites W4376634202 @default.
• W4307338033 doi "https://doi.org/10.1007/s10633-022-09898-4" @default.
• W4307338033 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36287318" @default.
• W4307338033 hasPublicationYear "2022" @default.
• W4307338033 type Work @default.
• W4307338033 citedByCount "0" @default.
• W4307338033 crossrefType "journal-article" @default.
• W4307338033 hasAuthorship W4307338033A5001517387 @default.
• W4307338033 hasAuthorship W4307338033A5048565684 @default.
• W4307338033 hasAuthorship W4307338033A5060936030 @default.
• W4307338033 hasBestOaLocation W43073380331 @default.
• W4307338033 hasConcept C118487528 @default.
• W4307338033 hasConcept C126322002 @default.
• W4307338033 hasConcept C128057223 @default.
• W4307338033 hasConcept C141071460 @default.
• W4307338033 hasConcept C2778233873 @default.
• W4307338033 hasConcept C2778823896 @default.
• W4307338033 hasConcept C2779491297 @default.
• W4307338033 hasConcept C2780303639 @default.
• W4307338033 hasConcept C2780837183 @default.
• W4307338033 hasConcept C2909675724 @default.
• W4307338033 hasConcept C2911091166 @default.
• W4307338033 hasConcept C29730261 @default.
• W4307338033 hasConcept C42219234 @default.
• W4307338033 hasConcept C548259974 @default.
• W4307338033 hasConcept C71924100 @default.
• W4307338033 hasConceptScore W4307338033C118487528 @default.
• W4307338033 hasConceptScore W4307338033C126322002 @default.
• W4307338033 hasConceptScore W4307338033C128057223 @default.
• W4307338033 hasConceptScore W4307338033C141071460 @default.
• W4307338033 hasConceptScore W4307338033C2778233873 @default.
• W4307338033 hasConceptScore W4307338033C2778823896 @default.
• W4307338033 hasConceptScore W4307338033C2779491297 @default.
• W4307338033 hasConceptScore W4307338033C2780303639 @default.
• W4307338033 hasConceptScore W4307338033C2780837183 @default.
• W4307338033 hasConceptScore W4307338033C2909675724 @default.
• W4307338033 hasConceptScore W4307338033C2911091166 @default.
• W4307338033 hasConceptScore W4307338033C29730261 @default.
• W4307338033 hasConceptScore W4307338033C42219234 @default.
• W4307338033 hasConceptScore W4307338033C548259974 @default.
• W4307338033 hasConceptScore W4307338033C71924100 @default.
• W4307338033 hasFunder F4320310064 @default.
• W4307338033 hasIssue "3" @default.
• W4307338033 hasLocation W43073380331 @default.
• W4307338033 hasLocation W43073380332 @default.
• W4307338033 hasLocation W43073380333 @default.
• W4307338033 hasOpenAccess W4307338033 @default.
• W4307338033 hasPrimaryLocation W43073380331 @default.
• W4307338033 hasRelatedWork W1898974057 @default.
• W4307338033 hasRelatedWork W2027274493 @default.
• W4307338033 hasRelatedWork W2070029350 @default.
• W4307338033 hasRelatedWork W2073918328 @default.
• W4307338033 hasRelatedWork W2088787531 @default.
• W4307338033 hasRelatedWork W2146000776 @default.
• W4307338033 hasRelatedWork W2318739344 @default.
• W4307338033 hasRelatedWork W2751621324 @default.
• W4307338033 hasRelatedWork W2995810889 @default.

• next